Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Current Taxes (2018 - 2022)

Historic Current Taxes for Regenxbio (RGNX) over the last 5 years, with Q1 2022 value amounting to $12.7 million.

  • Regenxbio's Current Taxes rose 21640.45% to $12.7 million in Q1 2022 from the same period last year, while for Mar 2022 it was $12.7 million, marking a year-over-year increase of 21640.45%. This contributed to the annual value of $11.3 million for FY2021, which is 26124.4% up from last year.
  • Per Regenxbio's latest filing, its Current Taxes stood at $12.7 million for Q1 2022, which was up 21640.45% from $11.3 million recorded in Q4 2021.
  • Regenxbio's 5-year Current Taxes high stood at $12.7 million for Q1 2022, and its period low was $508000.0 during Q3 2019.
  • Its 5-year average for Current Taxes is $3.8 million, with a median of $1.8 million in 2018.
  • As far as peak fluctuations go, Regenxbio's Current Taxes plummeted by 7687.58% in 2019, and later soared by 26124.4% in 2021.
  • Regenxbio's Current Taxes (Quarter) stood at $726000.0 in 2018, then plummeted by 30.03% to $508000.0 in 2019, then skyrocketed by 517.13% to $3.1 million in 2020, then soared by 261.24% to $11.3 million in 2021, then increased by 11.89% to $12.7 million in 2022.
  • Its last three reported values are $12.7 million in Q1 2022, $11.3 million for Q4 2021, and $4.0 million during Q1 2021.